To further verify the critical role of EZH2 in FAK-mediated anti-senescence signaling, we explored whether EZH2 overexpression bypasses FAK-inhibition-induced cellular senescence in non-small cell lung cancer cells. The gene discussed is EZH2; the disease is non-small cell lung carcinoma.